Bioactive Compounds
-
B7209 B2Summary: Promotes inclusion formation in cellular models of Huntington's disease and Parkinson's disease -
B7275 NBI 35965 hydrochlorideTarget: CRF1 ReceptorsSummary: CRF1 antagonist -
B7352 CD 3254Summary: RXRα agonist,potent and selective -
B7484 SR 48692Summary: nonpeptide neurotensin antagonist -
B7498 A 1120Summary: retinol-binding protein 4 (RBP4) ligand -
B7621 OctMABSummary: Dynamin inhibitor -
B7625 GW 803430Summary: melanin-concentrating hormone receptor 1 (MCH1) antagonist -
B7664 BAY 41-2272Summary: Activator of soluble guanylyl cyclase (sGC) -
B7731 Necrosulfonamide9 CitationTarget: Mixed lineage kinase domain-like protein (MLKL)Summary: Necroptosis inhibitor -
B5009 MetaphitSummary: Acylator of PCP and σ-receptors

